The sepsis clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline sepsis drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
This prospective observational study was conducted at a tertiary cancer center from November 2018 to June 2020. Patients age 15 years and older with confirmed leukemia or lymphomas undergoing ...
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project Eligible patients were ...
Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight The non-small cell lung cancer clinical trial analysis report ...
The use of adjuvant chemotherapy in patients with breast cancer may be guided by clinicopathological factors and a score based on a 21-gene assay to determine the risk of recurrence. Whether the level ...
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The hemophilia clinical trial analysis report delivers important insights ...
Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...
Women were generally excluded from clinical trials until the 1990s; in 1993, the NIH inclusion policy was codified into ...
Correspondence to Dr Roula Kotsifaki, Rehabilitation Department, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar; argyro.kotsifaki{at}aspetar.com This guideline was developed to inform ...